- Home
- HFWA vs ORGO Comparison
HFWA vs ORGO Comparison
Compare HFWA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HFWA | ORGO |
|---|---|---|
| Founded | 1927 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 748.4M | 624.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HFWA | ORGO |
|---|---|---|
| Price | $25.37 | $4.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $29.33 | $8.00 |
| AVG Volume (30 Days) | 187.7K | ★ 1.3M |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | ★ 53.03 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | $232,877,000.00 | ★ $465,218,000.00 |
| Revenue This Year | $21.61 | $8.14 |
| Revenue Next Year | $29.10 | $6.33 |
| P/E Ratio | $15.29 | ★ N/A |
| Revenue Growth | ★ 14.16 | 2.24 |
| 52 Week Low | $19.84 | $2.61 |
| 52 Week High | $26.58 | $7.08 |
Technical Indicators
Market Signals| Indicator | HFWA | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 72.07 | 45.43 |
| Support Level | $24.01 | $4.61 |
| Resistance Level | $25.53 | $5.83 |
| Average True Range (ATR) | 0.56 | 0.22 |
| MACD | 0.18 | -0.09 |
| Stochastic Oscillator | 91.46 | 18.66 |
Price Performance
Historical ComparisonAbout HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.